Pregnancy in essential thrombocythemia during aspirin treatment.
BACKGROUND
Essential thrombocythemia is a rare disease of unknown origin characterized by abnormal increase in the platelet count.


METHODS
We report a case diagnosed in a woman who had had an early miscarriage in her first pregnancy, a voluntary abortion because a fetal chromosomal aberration in the second pregnancy and at last a third normal pregnancy. Treatment with low-dose aspirin (100 mg/day) and the use of low molecular weight heparin in the last three weeks of gestation appears to improve the obstetric outcome.
Ruggeri
Zaira
Z
Dipartimento di Scienze Ginecologiche, Ostetriche e Medicina della Riproduzione, Università di Messina, Messina, Italy.
Cannata
Maria L
ML
Stella
Narciso Carlo
NC
Corrado
Francesco
F
D000328:Adult; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D002585:Cesarean Section; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010298:Parity; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D013920:Thrombocythemia, Essential / Q000188:drug therapy*
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin